Previous 10 | Next 10 |
Gainers: Cyngn (CYN) +70%. Sky Harbour Group (SKYH) +28%. Redbox Entertainment (RDBX) +25%. Wrap Technologies (WRAP) +18%. Inozyme Pharma (INZY) +16%. MedAvail Holdings (MDVL) +14%. Red Cat Holdings (OTCQB:RCAT) +13%. Pulse Biosciences (PLSE) +12%. United Airlines Holdings (UAL) +11%. Alpha T...
Gainers: Checkmate Pharmaceuticals (CMPI) +332%. Sono Group (SEV) +66%. ToughBuilt Industries (TBLT) +55%. Petros Pharmaceuticals (PTPI) +40%. Axsome Therapeutics (AXSM) +25%. Cyren (CYRN) +22%. Super Micro Computer (SMCI) +21%. Pulse Biosciences (PLSE) +18%. Annexon (ANNX) +18%. Olema Pharma...
Bioelectric medicine company Pulse Biosciences (NASDAQ:PLSE) announced a rights offering for all shareholders of record as of market close on April 25. The rights offering will start on or about May 4. The healthcare company intends to issue non-transferable subscription rights to stockh...
Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a novel bioelectric medicine company, today announced that the Company’s Board of Directors has approved a rights offering available to all holders of record of the Company&...
The shares of healthcare equipment maker, Pulse Biosciences (PLSE -27.2%), closed at a record low on Friday after H.C. Wainwright slashed its price target by more than half citing the company’s 4Q 2021 results. The analyst Swayampakula Ramakanth cites a change in the company’s s...
Gainers: Weidai (WEI) +68%. Manning & Napier (MN) +41%. Chicken Soup for the Soul Entertainment (CSSE) +28%. Hudson Capital (HUSN) +26%. Guardforce AI (GFAI) +19%. U.S. Xpress Enterprises (USX) +20%. Blackboxstocks (BLBX) +17%. Takung Art (TKAT) +17%. Borr Drilling (BORR) +17%. Clever Lea...
Gainers: ORIC Pharmaceuticals (ORIC) +14%. Unity Biotechnology (UBX) +13%. Applied Therapeutics (APLT) +11%. Genetron (GTH) +11%. Clarus Therapeutics (CRXT) +8%. Losers: SELLAS Life Sciences SLS -39%. Pulse Biosciences (PLSE) -22%. Spero Therapeutics SPRO...
Pulse Biosciences, Inc. (PLSE) Q4 2021 Earnings Conference Call March 31, 2022, 04:30 PM ET Company Participants Philip Taylor - Investor Relations Darrin Uecker - President & Chief Executive Officer Ed Ebbers - Executive Vice President, General Manager of Dermatology Sandy Gardiner - Exe...
Pulse Biosciences press release (NASDAQ:PLSE): Q4 GAAP EPS of -$0.52 misses by $0.01. Revenue of $0.84M beats by $0.03M. Cash, cash equivalents and investments totaled $28.6 million as of December 31, 2021. For further details see: Pulse Biosciences GAAP EPS of -$0.52 misses by $0.01, r...
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced financial results for the fourth quarter and full year of 2021. Company Updates ...
News, Short Squeeze, Breakout and More Instantly...
Pulse Biosciences Inc Company Name:
PLSE Stock Symbol:
NASDAQ Market:
Pulse Biosciences Inc Website:
Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, announced today the closing of its rights offering and the fi...
2024-06-25 21:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-15 22:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...